4.7 Letter

Lck is a key target of imatinib and dasatinib in T-cell activation

Journal

LEUKEMIA
Volume 24, Issue 4, Pages 896-900

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2010.11

Keywords

-

Funding

  1. PHS HHS [078170] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available